InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.410
+0.030 (1.26%)
Sep 16, 2025, 4:00 PM EDT - Market closed
InspireMD Employees
As of December 31, 2024, InspireMD had 86 total employees, including 85 full-time and 1 part-time employees. The number of employees increased by 20 or 30.30% compared to the previous year.
Employees
86
Change (1Y)
20
Growth (1Y)
30.30%
Revenue / Employee
$82,163
Profits / Employee
-$481,174
Market Cap
100.55M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 86 | 20 | 30.30% |
Dec 31, 2023 | 66 | 10 | 17.86% |
Dec 31, 2022 | 56 | 4 | 7.69% |
Dec 31, 2021 | 52 | 4 | 8.33% |
Dec 31, 2020 | 48 | 0 | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NSPR News
- 21 days ago - InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - InspireMD Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors - GlobeNewsWire
- 6 weeks ago - InspireMD Announces Combined Financings of $58 Million - GlobeNewsWire
- 2 months ago - InspireMD to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewsWire
- 3 months ago - InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewsWire